Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, we would
like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 5th February
2025 inter alia, to consider following business. -
1.) To approve and take on record the Un-Audited Financia l Results of the Company for the quarter ended on 31''t
December 2024.
2.) To approve and consider the appointment of Mr. Kelash Bunkar as Whole time Director and Chief Financial Officer
of the Company.
3.) To consider the resignation of Mr. Niraj Vaghela from designation of Whole time Director and Chief Financial
Officer of the Company.
4.)To approve and consider the appointment of Mr. Aman Patel as Director of the Company.
5.) To consider the resignation of Ms. Komal Chauhan from directorship of the Company.
6.) Any other matter with the permission of the board which the Board may think fit.
Thanking You.
|